FDA Announces Withdrawal Of Unapproved Suppository Drugs For Nausea/Vomiting
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency also is revoking NDA approval of King’s Tigan trimethobenzamide suppositories.
You may also be interested in...
Ergotamine Drugs Are Latest Target In FDA Crackdown On Unapproved Medications
FDA warns eight manufacturers and 12 distributors to stop marketing unapproved drugs that contain ergotamine tartrate.
FDA Kicks Off Unapproved Drug Crack-Down With Carbinoxamine Enforcement
FDA is focusing initially on drugs containing the antihistamine carbinoxamine because of safety concerns in children.
Hologic's Adiana Permanent Birth Control Device Takes On Conceptus' Essure
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: